王儀群

【摘要】 目的：研究采用肌功能矯治器與直絲弓矯正技術(shù)聯(lián)合矯正上頜前突的臨床效果。方法：選取筆者所在醫(yī)院2016年7月-2018年6月收治的上頜前突患者80例作為研究對(duì)象，將其隨機(jī)分為兩組，即對(duì)照組和研究組，每組40例。對(duì)照組實(shí)施直絲弓矯治技術(shù)矯正，研究組采取肌功能矯治器與直絲弓矯正技術(shù)聯(lián)合矯正。對(duì)比兩組患者測(cè)量指標(biāo)變化及滿意度。結(jié)果：研究組患者SNB、SN-OP、SN-MP、U1-SN明顯優(yōu)于對(duì)照組，且患者滿意度明顯高于對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論：上頜前突患者會(huì)有口呼吸不良習(xí)慣，肌功能矯治器能夠緩解患者口呼吸情況，避免支抗喪失，聯(lián)合直絲弓矯正技術(shù)，臨床療效顯著，值得推廣應(yīng)用。

【關(guān)鍵詞】 肌功能矯治器; 直絲弓矯正技術(shù); 上頜前突

doi：10.14033/j.cnki.cfmr.2019.12.006 文獻(xiàn)標(biāo)識(shí)碼 A 文章編號(hào) 1674-6805（2019）12-00-03

Clinical Effect of Using Myofunctional Appliance and Straight Wire Arch Correction Technique to Correct Maxillary Protrusion/WANG Yiqun.//Chinese and Foreign Medical Research，2019，17（12）：-16

【Abstract】 Objective：To study the clinical effect of using myofunctional applianc and straight wire arch correction technique to correct maxillary protrusion.Method：A total of 80 patients with maxillary protrusion admitted to the hospital from July 2016 to June 2018 were selected as the research subjects，and they were randomly divided into two groups，the control group and the study group，40 cases in each group.In the control group，straight wire arch correction technique was used，and in the study group，myofunctional appliance was used in combination with the straight wire arch correction technique.The changes of measurement indexes and satisfaction were compared between the two groups of patients.Result：The patients SNB，SN-OP，SN-MP and U1-SN in the study group were significantly better than those of the control group，and the patient satisfaction was significantly higher than that of the control group，the differences were statistically significant（P<0.05）.Conclusion：Patients with maxillary protrusion have bad breathing habits，myofunctional appliance can relieve the mouth breathing situation of patients，avoid loss of anchorage，combined with straight wire arch correction technique，clinical efficacy is significant，it is worth popularizing.

【Key words】 Myofunctional appliance; Straight wire arch correction technique; Maxillary protrusion

First-authors address：Qujing First Peoples Hospital，Qujing 655000，China

據(jù)報(bào)道，在全部肺癌中非小細(xì)胞肺癌發(fā)生率為80%，且有75%左右患者處于中晚期，5年生存率極低[1]。隨著我國人口老齡化的急劇增加，65歲以上患者中有超過50%患有晚期非小細(xì)胞肺癌，同時(shí)70歲以上患者中有30%～40%患有非小細(xì)胞肺癌，通常死于臟器功能衰竭及并發(fā)癥[2-3]。因此，如何控制老年晚期非小細(xì)胞肺癌患者病情進(jìn)展，延長生存時(shí)間已成為當(dāng)前需要解決的重要問題。以往治療通常選取鉑類+第三代細(xì)胞毒藥物的兩藥聯(lián)合方案，但鑒于老年患者機(jī)體弱、機(jī)體生理功能差等方面情況，本文對(duì)其采取單一化療藥物方案，即吉西他濱單獨(dú)用藥化療方案、多西他賽單獨(dú)用藥化療方案，效果

如下。

1 資料與方法

1.1 一般資料

以2014年2月-2016年10月作為病例納入時(shí)間段，從筆者所在醫(yī)院隨機(jī)抽選66例老年晚期非小細(xì)胞肺癌患者作為本次研究的調(diào)查對(duì)象。納入標(biāo)準(zhǔn)：（1）經(jīng)病理學(xué)檢查確診為晚期非小細(xì)胞肺癌;（2）Karnofsky評(píng)分>70分[4];（3）預(yù)計(jì)生存期>3個(gè)月;（4）體力狀況評(píng)分為0～1分。排除標(biāo)準(zhǔn)：（1）合并認(rèn)知功能障礙、精神類疾病、肝腎功能不全等情況;（2）近期接受過抗腫瘤藥物治療;（3）研究過程后者能夠因個(gè)人原因主動(dòng)退出[5]。依照不同的治療該藥物將其分為以下兩組，即A組33例，男女比例18∶15，年齡60～78歲，平均（70.64±4.32）歲，包括腺癌